Skip to Content

Peleg Laboratory

Mechanisms Of Disease Caused By Hospital-Acquired Pathogens

Welcome to the Peleg Lab

Our research program focuses on the mechanisms of pathogenesis of important hospital-acquired pathogens and the identification of novel therapeutic targets. More specifically, multidrug-resistant Gram-negative bacteria, including Acinetobacter baumannii, and the Gram-positive bacterial pathogen, Staphylococcus aureus.

We're part of the Monash Biomedicine Discovery Institute and a member of the Infection & Immunity Program and the Department of Microbiology.

Professor Anton Peleg

My global research connections, partners and funding can be viewed on my Monash Research Profile.

If you are a student interested in doing research in our lab, visit Supervisor Connect.

Click the links below to connect with me on ORCID and Google Scholar.

Twitter

Our research

We combine bacterial genetic techniques with exciting in vitro, ex vivo and in vivo infection model systems (mammalian and non-mammalian [eg. Zebrafish]) to characterise the role of novel genes in virulence and antimicrobial resistance. Our over-arching goal is to identify new targets that may be amenable for future drug development, with a focus on microbial virulence, persistence and adaptation.

  • Antimicrobial resistance (AMR) and host immune evasion in Staphylococcus aureus

  • Regulation of pathogenesis and virulence in Acinetobacter baumannii

  • Emerging antimicrobial resistance & transmission by lateral gene transfer

  • Biofilms and infections on medical devices

Lab members

We are committed to excellence in research.

Publications

View our chosen highlighted key publications.

Read more

News

We want to share our research discoveries & successes with you.

Read more

Join Our Lab

We're always interested in collaborating with bright and motivated researchers, clinicians and industry. Whether you want to research, study or partner with us to accelerate our discoveries, find out about the work we do.

Find out more